Support Programs Designed Around the Patient

Pharmaceutical companies invested more than $22 billion in patient support programs in 2024, according to Zelthy's 2026 analysis of the patient support landscape. Yet only 3 to 8% of eligible patients use them. For a category built specifically to help patients start and stay on treatment, that gap is hard to ignore.
Awareness remains one of the biggest barriers to patient support programs working at all. Many eligible patients never learn these resources exist, and the ones who do often abandon them early because the experience feels disjointed.
For the patients that do find the program, most notice within the first few interactions whether a program was designed around them or if it was built around the pharmaceutical company’s internal processes. It shows up in being connected with representatives who already know their case, in paperwork that doesn't ask them to repeat information they already gave someone else weeks earlier, and in resources that feel curated specifically for them.
Connected Support that starts with the patient
Most patient support programs are built piece by piece. A call center is added, then an app, then a financial assistance tool, then an educational hub. Each piece may work well on its own, but patients experience a program as one continuous relationship, one that extends far beyond the moment a prescription is written. The disconnect between these parts is exactly what breaks that experience, leaving patients to repeatedly explain their situation rather than feeling understood by a system that accounts for who they are.
At Snow, support is designed as a single system from the start. Snow takes real patient insights and data to develop a more meaningful, more genuine approach to how patients move through a diagnosis and treatment. The goal is support that feels considered at every step, beyond just the moments a brand has identified as relevant.
It also starts with the patients themselves. The strongest programs are shaped by direct input from real patients, including the ones who do not think they need extra support, because that input often reveals gaps a team would never catch on its own. We know that patients' needs are different depending on where they are in their journey. A newly diagnosed patient is processing a different set of questions and emotions than someone who has been managing a chronic condition for years, and Snow helps clients create programs that recognize that distinction rather than treating every patient the same way.
The result is support built with intention at every stage, grounded in data, shaped by real patient experience, and designed to meet a patient where they are rather than where a program assumes they should be.
Why this matters for DTC marketers
Recent analysis published in Pharmaceutical Commerce found that patients who receive robust engagement in their first 30 days, through outreach, education and onboarding support, show meaningfully stronger persistence on treatment than patients with minimal early contact, and that advantage holds well beyond the first month.
This is where Snow's approach to patient relationships extends naturally into support. The same principle that shapes every Patient Ambassador® program applies here. Real input from real patients, built into the design from day one, produces support that leads to healthier outlooks for patients and stronger, more trusted experiences for the brands behind them. When Patient Ambassador® programs and patient support programs are truly integrated rather than siloed, they amplify these benefits, creating a continuous cycle of patient insight, program refinement, and sustained engagement that drives program awareness and measurable long-term outcomes for patients and brands alike.

